Safety Alerts

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd)

Published
Source
PSNC Dispensing & Supply News
Imported
6 Jun 2026

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) Drug alert number: EL(26)A/23 Date issued: 11 May 2026 Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets. DMRC reference number: DMRC- 39394163 Marketing Authorisation Holder: Milpharm Limited Medicine Details Product name: [...]

The post MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) appeared first on Community Pharmacy England.

View original alert (opens in a new tab)

Important: This alert is gathered automatically for information only. Always refer to the original source and follow your practice’s own clinical governance procedures.

The weekly digest lists every alert published in a week, grouped by source. View the weekly digest

Back to Safety Alerts